Strox Biopharmaceuticals, LLC
Records under this name other than patents Strox Biopharmaceuticals, LLC holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned.
Showing 1 to 5 of 5 · Back to Strox Biopharmaceuticals, LLC
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 6,322,788 | Anti-bacterial antibodies and methods of use Term ended Term ended Aug 20, 2019 · USPTO record | Term ended | Term ended Aug 20, 2019 | USPTO record |
| US 7,795,402 | Anti-Staphylococcus aureus antibodies Term ended Ended no later than Aug 20, 2019 · USPTO record | Term ended | Ended no later than Aug 20, 2019 | USPTO record |
| US 8,142,780 | Anti-bacterial antibodies Term ended Ended no later than Aug 20, 2019 · USPTO record | Term ended | Ended no later than Aug 20, 2019 | USPTO record |
| US 7,569,677 | Antibiotic-conjugated antibodies Lapsed on the fee record Ended Aug 4, 2017 · USPTO record | Lapsed on the fee record | Ended Aug 4, 2017 | USPTO record |
| US 6,475,788 | Anti-bacterial antibodies and methods of use Lapsed on the fee record Ended Nov 5, 2014 · USPTO record | Lapsed on the fee record | Ended Nov 5, 2014 | USPTO record |